Concepedia

Dawn Averitt

DA

Statistics

Publications

3

Citations

124

H-Index

3

Active since

2006

Affiliations

GlaxoSmithKline (United States)(Current)

Dawn Averitt is an author at GlaxoSmithKline (United States) specializing in public health, outcomes research, and health policy.

Top concepts

Publications per year

2006–2023

3

Publications

3

A prospective, 96‐week study of the impact of Trizivir<sup>®</sup>, Combivir<sup>®</sup>/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral‐naive patients: effect of sex and ethnicity

A Rodriguez‐French, Dawn Averitt, Mark S. Shaefer et al. · HIV Medicine · 2006 · 69 citations · Full text

The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy

Karine Dubé, Shadi Eskaf, David Evans et al. · AIDS Research and Human Retroviruses · 2019 · 37 citations · Full text

, , +21

Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States

Karine Dubé, Elizabeth Barr, Morgan M. Philbin et al. · HIV Research & Clinical Practice · 2023 · 18 citations · Full text

1–3 of 3